Meet Dr. Kristen Hege, who is inspiring the next generation of female physicians and scientists to gain strength from nature!
Dr. Kristen Hege, senior vice president of Early Clinical Development, Hematology/Oncology & Cell Therapy at Bristol Myers Squibb, has been at the forefront of drug discovery and translational development for over two decades and is a leader in the burgeoning cell therapy field. Kristen and her team of clinician-scientists are pioneering new therapies that improve the standard of care for people with cancer. Kristen oversees a team of physicians and clinical scientists investigating different treatment modalities, such as chimeric antigen receptor (CAR) T cells, bispecific T-cell engagers, monoclonal antibodies and next-generation small molecules across multiple different cancers.